Year: 2025

Reference is made to the private placement (the “Private Placement“) and the retail offering through PrimaryBid (the “PrimaryBid Offering“) announced by Zelluna ASA on 3 November 2025. Please see the attached PDMR-forms related to (i) allocation of shares in the Private Placement; and (ii) share lending to facilitate settlement of tranche 1 of the Private Placement and the PrimaryBid Offering.  Attachment20251104 – PDMR attachment

SAN DIEGO, Nov. 03, 2025 (GLOBE NEWSWIRE) — Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics for the treatment of metabolic diseases, today announced that (i) on October 20, 2025, one new employee was granted an inducement award consisting of a stock option to purchase 23,602 shares of common stock, (ii) on October 28, 2025, three new employees were granted inducement awards consisting of stock options to purchase an aggregate of 49,849 shares of common stock and (iii) on November 3, 2025, one new employee was granted an inducement award consisting of a stock option to purchase 14,766 shares of common stock. Each option was granted pursuant to the Aardvark Therapeutics, Inc. 2025 Inducement Equity Incentive Plan, and was granted...

Successful private placement and retail offering – Zelluna ASA raises NOK 58 million to advance the world’s first “off-the-shelf” TCR-NK therapy, ZI-MA4-1, into Phase I clinical trials and develop the pipeline Strong support from existing shareholders, management and board members with extensive life science and cell therapy experience. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE’S REPUBLIC OF CHINA, SOUTH AFRICA, NEW ZEALAND, JAPAN OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL Oslo, 3 November 2025: Zelluna ASA (“Zelluna” or the “Company”), a company pioneering allogeneic ‘off the shelf’ T Cell Receptor based Natural Killer...

SPARTANBURG, S.C., Nov. 03, 2025 (GLOBE NEWSWIRE) — Denny’s Corporation (the “Company”) (NASDAQ: DENN), owner and operator of Denny’s Inc. (“Denny’s”) and Keke’s Inc. (“Keke’s”) today announced that it will no longer hold its third quarter earnings conference call originally scheduled for 4:30 p.m. Eastern Time today in light of the announced transaction with TriArtisan Capital Advisors LLC, Treville Capital Group and Yadav Enterprises, Inc. Denny’s will release third quarter financial results after the stock markets close today. About Denny’s Corporation Denny’s Corporation is one of America’s largest full-service restaurant brands based on number of restaurants. As of June 25, 2025, the Company consisted of 1,558 restaurants, 1,474 of which were franchised and licensed...